High-level Policy Makers Forum
Achieving Self-sufficiency in Safe Blood and Blood Products, based on Voluntary Non-remunerated Donation
Equitable and timely access to safe blood and blood products, which include blood components for transfusion and plasma‐derived medicinal products, and their appropriate use is an essential component of health service provision and universal health coverage. In 2010, the World Health Assembly deliberated on challenges to the availability, safety and quality of blood products and defined self‐sufficiency in the supply of safe blood and blood products based on VNRD, and the security of that supply, as important national goals to prevent blood shortages and meet the transfusion requirements of the patient population. Resolution WHA63.12 urged Member States "to take all necessary steps to establish, implement and support nationally‐coordinated, efficiently‐managed and sustainable blood and plasma programmes according to the availability of resources, with the aim of achieving self‐sufficiency". In this context, self‐sufficiency means that the national needs of patients for safe blood and blood products, as assessed within the framework of the national health system, are met in a timely manner and that patients have equitable access to transfusion services and blood products. With an increasing needs for blood and blood products globally, many countries are facing challenges in making sufficient supplies of the blood and blood products available and sustainable while ensuring their quality and safety from known and emerging threats to public health. Consequently, a large number of patients who require life-saving transfusion therapy still lack access to safe blood and blood products.